← SynDRA
ESMOLOL
SynDRA canonical compound SYN0001764 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ADRB1 |
|---|
| Mechanism of action | Adrenergic receptor antagonist |
|---|
| Indication | hypertension | ventricular tachycardia (VT) |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRB1 ANTAGONIST
- Beta-1 adrenergic receptor antagonist
- ADRB2 ANTAGONIST
- Beta-2 adrenergic receptor antagonist
Drug classes
- Adrenergic beta-Antagonists
- beta-Adrenergic Blocker
- Adrenergic Agents
- Adrenergic Antagonists
- Adrenergic beta-1 Receptor Antagonists
- Neurotransmitter Agents
ATC classes
- C07A · BETA BLOCKING AGENTS
Cross-references
Synonyms
- brevibloc
- esmolol hydrochloride
- esmolol HCl
- ASL-8052-001
- ASL 8052-001
- Brevibloc (TN)
- Esmolol (INN)
- Esmolol [INN:BAN]
- Methyl p-[2-hydroxy-3-(isopropylamino)propoxy]hydrocinnamate
- Methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate
- Methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate
- Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate
- Methyl 3-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]propanoate
- Methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate
- Benzenepropanoic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, methyl ester
- (+-)-Esmolol
- (+-)-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate
- MDY902UXSR
- methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate
- esmololum
- RefChem:56563
- CHEBI:4856
- DTXCID702995
- C07AB09
- (+/-)-esmolol
- MFCD00864566
- ESMOLOL [INN]
- NCGC00185766-01
- UNII-MDY902UXSR
- BRN 5287174
- SR-01000763706
- Esmolol Impurity 106
- ESMOLOL [VANDF]
- ESMOLOL [MI]
- ESMOLOL [WHO-DD]
- SCHEMBL3605
- GTPL7178
- CHEBI:88206
Look up ESMOLOL in the interactive SynDRA portal →